Home › Funds › Rock Springs Capital Management LP › MBX
Rock Springs Capital Management LP position in MBX
MBX BIOSCIENCES INC · Health Care
Rock Springs Capital Management LP reported holding 275,347 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$16.1M, representing 0.87% of its reported portfolio and ranking #38 among its reported holdings. Rock Springs Capital Management LP has disclosed MBX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's MBX position evolved
Rock Springs Capital Management LP first disclosed a stake in MBX in Q3 2025 at 282,624 shares (US$4.9M). The position peaked in Q2 2026 at 298,218 shares, worth US$16.5M. Across 5 filings, Rock Springs Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 275,347 shares valued at US$16.1M — a reduction of -22,871 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 282.62K | $4.95M | New |
| Q4 2025 | 282.62K | $8.91M | Hold |
| Q1 2026 | 287.97K | $8.60M | Add |
| Q2 2026 | 298.22K | $16.46M | Add |
| Q3 2026 | 275.35K | $16.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MBX and 13F data
MBX (MBX BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$199.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MBX
- Frazier Life Sciences Management, L.P. 6.65M sh · $367.19M · Q2 2026
- Paradigm Biocapital Advisors LP 3.77M sh · $221.17M · Q3 2026
- NEA Management Company, LLC 3.61M sh · $199.52M · Q2 2026
- ORBIMED ADVISORS LLC 3.43M sh · $189.27M · Q2 2026
- NVP Associates, LLC 2.14M sh · $125.23M · Q3 2026
- Aaron Wealth Advisors LLC 1.18M sh · $68.92M · Q3 2026
- Kynam Capital Management, LP 934.80K sh · $54.80M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 873.49K sh · $51.20M · Q3 2026
- Parkman Healthcare Partners LLC 716.54K sh · $42.00M · Q3 2026
- BRAIDWELL LP 710.88K sh · $39.24M · Q2 2026
- TCG Crossover Management, LLC 650.00K sh · $38.10M · Q3 2026
- Deep Track Capital, LP 640.00K sh · $37.52M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held MBX?
Rock Springs Capital Management LP has disclosed MBX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Rock Springs Capital Management LP's current position in MBX?
As of Q3 2026, Rock Springs Capital Management LP holds 275.35K shares of MBX (MBX BIOSCIENCES INC), valued at $16.14M, representing 0.87% of its reported portfolio and ranking #38.
Has Rock Springs Capital Management LP been buying or selling MBX?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in MBX. The position peaked in Q2 2026 at 298.22K shares.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.